Generic Lovenox & An FDA Precedent: Pan Explains
9 CommentsBy Ed Silverman // July 30th, 2010 // 9:35 am
• Pharma Blog » Archives
Follow On Biologics
Merck Wants To Develop Follow-On Biologics
2 CommentsBy Ed Silverman // December 9th, 2008 // 10:11 am
FTC Holds Roundtable On Follow-On Biologics
4 CommentsBy Ed Silverman // November 21st, 2008 // 7:22 am
Specialty Med Prices Greatly Outstrip Inflation
1 CommentBy Ed Silverman // September 25th, 2008 // 1:07 pm
FTC Reviewing Follow-On Biologics And Competition
Make a commentBy Ed Silverman // August 28th, 2008 // 4:38 pm
Insmed Develops Biologic For Amgen’s Neupogen
2 CommentsBy Ed Silverman // July 10th, 2008 // 9:02 am
The Biosimilar Pathway Is Filled With Obstacles
Make a commentBy Ed Silverman // June 17th, 2008 // 2:28 pm
How Do You Spell Biogenerics? G-R-I-D-L-O-C-K
Make a commentBy Ed Silverman // February 14th, 2008 // 5:01 pm